The immunobiology of prion diseases

Nature Reviews Immunology

Volumn 13, Issue 12, 2013, Pages 888-902

  Aguzzi, Adriano ^a   Nuvolone, Mario ^b   Zhu, Caihong ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AMYLOID BETA PROTEIN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR5; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT RECEPTOR; IMMUNOLOGIC AGENT; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGOMER; PRION PROTEIN; PRION PROTEIN[105-125]; RECOMBINANT PRION PROTEIN[23-230]; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; ATYPICAL BOVINE SPONGIFORM ENCEPHALOPATHY; ATYPICAL SCRAPIE; B LYMPHOCYTE; BOVINE SPONGIFORM ENCEPHALOPATHY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CHRONIC WASTING DISEASE; COMPLEMENT SYSTEM; DENDRITIC CELL; FAMILIAL CREUTZFELDT JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; FELINE SPONGIFORM ENCEPHALOPATHY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HEMATOPOIETIC CELL; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; IMMUNOBIOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; KURU; LYMPHOID ORGAN; MACROPHAGE; MACROPHAGE ACTIVATION; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; PEYER PATCH; PHAGOCYTOSIS; POST EXPOSURE PROPHYLAXIS; PRION; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SCRAPIE; SPONGIFORM ENCEPHALOPATHY OF ZOO ANIMAL; SPORADIC CREUTZFELDT JAKOB DISEASE; SPORADIC FATAL INSOMNIA; STROMA CELL; T LYMPHOCYTE; TONSIL; TRANSMISSIBLE MINK ENCEPHALOPATHY; VARIANT CREUTZFELDT JAKOB DISEASE; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOID TISSUE; MICE; PRION DISEASES; PRIONS; PROTEIN TRANSPORT; PRPC PROTEINS; PRPSC PROTEINS;

EID: 84888311810     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3553     Document Type: Review

References (187)

1. Cuille, J. & Chelle, P. L. Experimental transmission of trembling to the goat. Comptes Rendus Séances Acad. Sci. 208, 1058-1160 (1939).
2. Gajdusek, D. C. & Zigas, V. Degenerative disease of the central nervous system in New Guinea; the endemic occurrence of kuru in the native population. N. Engl. J. Med. 257, 974-978 (1957).
3. Duffy, P. et al. Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 290, 692-693 (1974).
4. Will, R. G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996). (Pubitemid 26102546)
5. Llewelyn, C. A. et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421 (2004). (Pubitemid 38210057)
6. Bishop, M. T. et al. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain 136, 1139-1145 (2013).
7. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982). (Pubitemid 12089840)
8. Knowles, T. P. et al. An analytical solution to the kinetics of breakable filament assembly. Science 326, 1533-1537 (2009).
9. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996). (Pubitemid 26033075)
10. Linden, R. et al. Physiology of the prion protein. Physiol. Rev. 88, 673-728 (2008). (Pubitemid 351520090)
11. Aguzzi, A., Barres, B. A. & Bennett, M. L. Microglia: scapegoat, saboteur, or something else Science 339, 156-161 (2013).
12. Aguzzi, A. & Sigurdson, C. J. Antiprion immunotherapy: to suppress or to stimulate Nature Rev. Immunol. 4, 725-736 (2004).
13. Bueler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582 (1992).
14. Bremer, J. et al. Axonal prion protein is required for peripheral myelin maintenance. Nature Neurosci. 13, 310-318 (2010).
15. Miranda, A., Pericuesta, E., Ramirez, M. A. & Gutierrez-Adan, A. Prion protein expression regulates embryonic stem cell pluripotency and differentiation. PLoS ONE 6, e18422 (2011).
16. Petit, C. S. et al. Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease. Gastroenterology 143, 122-132.e15 (2012).
17. Nakato, G. et al. Cutting edge: Brucella abortus exploits a cellular prion protein on intestinal M cells as an invasive receptor. J. Immunol. 189, 1540-1544 (2012).
18. Nuvolone, M. et al. SIRP polymorphisms, but not the prion protein, control phagocytosis of apoptotic cells. J. Exp. Med. http://dx.doi.org/10.1084/ jem.20131274 (2013).
19. de Almeida, C. J. et al. The cellular prion protein modulates phagocytosis and inflammatory response. J. Leukoc. Biol. 77, 238-246 (2005). (Pubitemid 40315058)
20. Pan, K. M. et al. Conversion of-helices into-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA 90, 10962-10966 (1993).
21. Wang, F., Wang, X., Yuan, C. G. & Ma, J. Generating a prion with bacterially expressed recombinant prion protein. Science 327, 1132-1135 (2010).
22. Kimberlin, R. H. & Walker, C. A. Pathogenesis of scrapie in mice after intragastric infection. Virus Res. 12, 213-220 (1989). (Pubitemid 19088147)
23. Prinz, M. et al. Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. Am. J. Pathol. 162, 1103-1111 (2003). (Pubitemid 36350656)
24. Sigurdson, C. J. et al. Bacterial colitis increases susceptibility to oral prion disease. J. Infect. Dis. 199, 243-252 (2009).
25. Heppner, F. L. et al. Transepithelial prion transport by M cells. Nature Med. 7, 976-977 (2001).
26. Donaldson, D. S. et al. M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol. 5, 216-225 (2012).
27. Kujala, P. et al. Prion uptake in the gut: identification of the first uptake and replication sites. PLoS Pathog. 7, e1002449 (2011).
28. Carp, R. I. & Callahan, S. M. In vitro interaction of scrapie agent and mouse peritoneal macrophages. Intervirology 16, 8-13 (1981). (Pubitemid 12200956)
29. Beringue, V. et al. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J. Pathol. 190, 495-502 (2000). (Pubitemid 30163592)
30. Huang, F. P., Farquhar, C. F., Mabbott, N. A., Bruce, M. E. & MacPherson, G. G. Migrating intestinal dendritic cells transport PrPSc from the gut. J. Gen. Virol. 83, 267-271 (2002). (Pubitemid 34030831)
31. Raymond, C. R., Aucouturier, P. & Mabbott, N. A. In vivo depletion of CD11c+ cells impairs scrapie agent neuroinvasion from the intestine. J. Immunol. 179, 7758-7766 (2007).
32. Houston, F., Foster, J. D., Chong, A., Hunter, N. & Bostock, C. J. Transmission of BSE by blood transfusion in sheep. Lancet 356, 999-1000 (2000).
33. Mathiason, C. K. et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314, 133-136 (2006). (Pubitemid 44547758)
34. Collins, S. et al. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 353, 693-697 (1999). (Pubitemid 29103801)
35. Carp, R. I. Transmission of scrapie by oral route: effect of gingival scarification. Lancet 1, 170-171 (1982).
36. Mohan, J., Brown, K. L., Farquhar, C. F., Bruce, M. E. & Mabbott, N. A. Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. J. Dermatol. Sci. 35, 101-111 (2004). (Pubitemid 38969033)
37. Glaysher, B. R. & Mabbott, N. A. Role of the draining lymph node in scrapie agent transmission from the skin. Immunol. Lett. 109, 64-71 (2007). (Pubitemid 46365968)
38. Denkers, N. D. et al. Aerosol transmission of chronic wasting disease in white-tailed deer. J. Virol. 87, 1890-1892 (2013).
39. Haybaeck, J. et al. Aerosols transmit prions to immunocompetent and immunodeficient mice. PLoS Pathog. 7, e1001257 (2011).
40. Nichols, T. A. et al. Intranasal inoculation of white-tailed deer (Odocoileus virginianus) with lyophilized chronic wasting disease prion particulate complexed to montmorillonite clay. PLoS ONE 8, e62455 (2013).
41. Kincaid, A. E., Hudson, K. F., Richey, M. W. & Bartz, J. C. Rapid transepithelial transport of prions following inhalation. J. Virol. 86, 12731-12740 (2012).
42. Pattison, I. H. & Millson, G. C. Further observations on the experimental production of scrapie in goats and sheep. J. Comp. Pathol. 70, 182-193 (1960).
43. Sigurdson, C. J. et al. Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J. Gen. Virol. 80, 2757-2764 (1999). (Pubitemid 29458640)
44. Hadlow, W. J., Race, R. E. & Kennedy, R. C. Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J. Virol. 61, 3235-3240 (1987). (Pubitemid 17137678)
45. Hilton, D. A., Fathers, E., Edwards, P., Ironside, J. W. & Zajicek, J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352, 703-704 (1998).
46. Mohri, S., Handa, S. & Tateishi, J. Lack of effect of thymus and spleen on the incubation period of Creutzfeldt-Jakob disease in mice. J. Gen. Virol. 68, 1187-1189 (1987). (Pubitemid 17043528)
47. Beringue, V. et al. Facilitated cross-species transmission of prions in extraneural tissue. Science 335, 472-475 (2012).
48. Hill, A. F., Zeidler, M., Ironside, J. & Collinge, J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349, 99-100 (1997). (Pubitemid 27023429)
49. Fraser, H. & Dickinson, A. G. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226, 462-463 (1970).
50. Clarke, M. C. & Haig, D. A. Multiplication of scrapie agent in mouse spleen. Res. Vet. Sci. 12, 195-197 (1971).
51. Kimberlin, R. H. & Walker, C. A. The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res. 12, 201-211 (1989).
52. Kitamoto, T., Muramoto, T., Mohri, S., Doh-Ura, K. & Tateishi, J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 65, 6292-6295 (1991).
53. Lasmezas, C. I. et al. Immune system-dependent and-independent replication of the scrapie agent. J. Virol. 70, 1292-1295 (1996). (Pubitemid 26029059)
54. Brown, K. L., Stewart, K., Bruce, M. E. & Fraser, H. Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy. J. Gen. Virol. 78, 2707-2710 (1997). (Pubitemid 27470016)
55. Lavelle, G. C., Sturman, L. & Hadlow, W. J. Isolation from mouse spleen of cell populations with high specific infectivity for scrapie virus. Infect. Immun. 5, 319-323 (1972).
56. Clarke, M. C. & Kimberlin, R. H. Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. Vet. Microbiol. 9, 215-225 (1984). (Pubitemid 14069466)
57. Fraser, H. & Farquhar, C. F. Ionising radiation has no influence on scrapie incubation period in mice. Vet. Microbiol. 13, 211-223 (1987). (Pubitemid 17041374)
58. Klein, M. A. et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687-690 (1997). (Pubitemid 28016356)
59. Bueler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993). (Pubitemid 23201147)
60. Klein, M. A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Med. 4, 1429-1433 (1998). (Pubitemid 28553468)
61. Montrasio, F. et al. B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc. Natl Acad. Sci. USA 98, 4034-4037 (2001). (Pubitemid 32249893)
62. Blattler, T. et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389, 69-73 (1997). (Pubitemid 27387692)
63. Kaeser, P. S., Klein, M. A., Schwarz, P. & Aguzzi, A. Efficient lymphoreticular prion propagation requires PrPc in stromal and hematopoietic cells. J. Virol. 75, 7097-7106 (2001). (Pubitemid 32641597)
64. Brown, K. L. et al. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nature Med. 5, 1308-1312 (1999). (Pubitemid 29535610)
65. Loeuillet, C. et al. Prion replication in the hematopoietic compartment is not required for neuroinvasion in scrapie mouse model. PLoS ONE 5, e13166 (2010).
66. Krautler, N. J. et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 150, 194-206 (2012).
67. Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259 (2000). (Pubitemid 30367206)
68. Mabbott, N. A., Mackay, F., Minns, F. & Bruce, M. E. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nature Med. 6, 719-720 (2000). (Pubitemid 30469392)
69. Mabbott, N. A., McGovern, G., Jeffrey, M. & Bruce, M. E. Temporary blockade of the tumor necrosis factor receptor signaling pathway impedes the spread of scrapie to the brain. J. Virol. 76, 5131-5139 (2002). (Pubitemid 34441717)
70. Mabbott, N. A., Young, J., McConnell, I. & Bruce, M. E. Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77, 6845-6854 (2003). (Pubitemid 36666878)
71. Prinz, M. et al. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc. Natl Acad. Sci. USA 99, 919-924 (2002). (Pubitemid 34106611)
72. Klein, M. A. et al. Complement facilitates early prion pathogenesis. Nature Med. 7, 488-492 (2001). (Pubitemid 32298554)
73. Mabbott, N. A., Bruce, M. E., Botto, M., Walport, M. J. & Pepys, M. B. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nature Med. 7, 485-487 (2001). (Pubitemid 32298553)
74. Zabel, M. D. et al. Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J. Immunol. 179, 6144-6152 (2007).
75. McCulloch, L. et al. Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen. PLoS Pathog. 7, e1002402 (2011).
76. Heikenwalder, M. et al. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307, 1107-1110 (2005). (Pubitemid 40262116)
77. Seeger, H. et al. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310, 324-326 (2005). (Pubitemid 41457200)
78. Hamir, A. N., Kunkle, R. A., Miller, J. M. & Hall, S. M. Abnormal prion protein in ectopic lymphoid tissue in a kidney of an asymptomatic white-tailed deer experimentally inoculated with the agent of chronic wasting disease. Vet. Pathol. 43, 367-369 (2006).
79. Ligios, C. et al. PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nature Med. 11, 1137-1138 (2005). (Pubitemid 43093650)
80. Lacroux, C. et al. Prions in milk from ewes incubating natural scrapie. PLoS Pathog. 4, e1000238 (2008).
81. Konold, T. et al. Evidence of effective scrapie transmission via colostrum and milk in sheep. BMC Vet. Res. 9, 99 (2013).
82. Ligios, C. et al. Sheep with scrapie and mastitis transmit infectious prions through the milk. J. Virol. 85, 1136-1139 (2011).
83. O'Connor, T. et al. Lymphotoxin, but not TNF, is required for prion invasion of lymph nodes. PLoS Pathog. 8, e1002867 (2012).
84. Heikenwalder, M. et al. Lymphotoxin-dependent prion replication in inflammatory stromal cells of granulomas. Immunity 29, 998-1008 (2008).
85. Cole, S. & Kimberlin, R. H. Pathogenesis of mouse scrapie: dynamics of vacuolation in brain and spinal cord after intraperitoneal infection. Neuropathol. Appl. Neurobiol. 11, 213-227 (1985). (Pubitemid 15059499)
86. McBride, P. A. & Beekes, M. Pathological PrP is abundant in sympathetic and sensory ganglia of hamsters fed with scrapie. Neurosci. Lett. 265, 135-138 (1999). (Pubitemid 29210387)
87. Heggebo, R. et al. Disease-associated PrP in the enteric nervous system of scrapie-affected Suffolk sheep. J. Gen. Virol. 84, 1327-1338 (2003). (Pubitemid 36592627)
88. Glatzel, M., Heppner, F. L., Albers, K. M. & Aguzzi, A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31, 25-34 (2001). (Pubitemid 32757086)
89. van Keulen, L. J., Schreuder, B. E., Vromans, M. E., Langeveld, J. P. & Smits, M. A. Pathogenesis of natural scrapie in sheep. Arch. Virol. Suppl. 16, 57-71 (2000). (Pubitemid 33757365)
90. Sigurdson, C. J., Spraker, T. R., Miller, M. W., Oesch, B. & Hoover, E. A. PrP(CWD) in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease. J. Gen. Virol. 82, 2327-2334 (2001). (Pubitemid 32936766)
91. Haik, S. et al. The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nature Med. 9, 1121-1123 (2003). (Pubitemid 37173693)
92. Prinz, M. et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957-962 (2003). (Pubitemid 37376926)
93. Fevrier, B. et al. Cells release prions in association with exosomes. Proc. Natl Acad. Sci. USA 101, 9683-9688 (2004). (Pubitemid 38869296)
94. Gousset, K. et al. Prions hijack tunnelling nanotubes for intercellular spread. Nature Cell Biol. 11, 328-336 (2009).
95. Silveira, J. R. et al. The most infectious prion protein particles. Nature 437, 257-261 (2005). (Pubitemid 41294488)
96. Bartz, J. C., Kincaid, A. E. & Bessen, R. A. Retrograde transport of transmissible mink encephalopathy within descending motor tracts. J. Virol. 76, 5759-5768 (2002). (Pubitemid 34517926)
97. Spinner, D. S. et al. Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice. J. Virol. 82, 10701-10708 (2008). (Pubitemid 352691158)
98. Ishibashi, D. et al. Protective role of interferon regulatory factor 3-mediated signaling against prion infection. J. Virol. 86, 4947-4955 (2012).
99. Prinz, M. et al. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep. 4, 195-199 (2003). (Pubitemid 36322162)
100. Porter, D. D., Porter, H. G. & Cox, N. A. Failure to demonstrate a humoral immune response to scrapie infection in mice. J. Immunol. 111, 1407-1410 (1973).
101. McGovern, G., Brown, K. L., Bruce, M. E. & Jeffrey, M. Murine scrapie infection causes an abnormal germinal centre reaction in the spleen. J. Comp. Pathol. 130, 181-194 (2004). (Pubitemid 38279335)
102. Kingsbury, D. T., Smeltzer, D. A., Gibbs, C. J. Jr & Gajdusek, D. C. Evidence for normal cell-mediated immunity in scrapie-infected mice. Infect. Immun. 32, 1176-1180 (1981). (Pubitemid 11109825)
103. Mabbott, N. A. et al. Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J. Virol. 74, 3338-3344 (2000). (Pubitemid 30143759)
104. Heikenwalder, M. et al. Germinal center B cells are dispensable in prion transport and neuroinvasion. J. Neuroimmunol. 192, 113-123 (2007). (Pubitemid 350213123)
105. Sasaki, A., Hirato, J. & Nakazato, Y. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol. 86, 337-344 (1993). (Pubitemid 23280115)
106. Williams, A. E., Lawson, L. J., Perry, V. H. & Fraser, H. Characterization of the microglial response in murine scrapie. Neuropathol. Appl. Neurobiol. 20, 47-55 (1994). (Pubitemid 24078165)
107. Falsig, J. et al. Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. PLoS Pathog. 8, e1002985 (2012).
108. Falsig, J. et al. A versatile prion replication assay in organotypic brain slices. Nature Neurosci. 11, 109-117 (2008).
109. Kranich, J. et al. Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner. J. Exp. Med. 207, 2271-2281 (2010).
110. Hughes, M. M., Field, R. H., Perry, V. H., Murray, C. L. & Cunningham, C. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 58, 2017-2030 (2010).
111. Sharief, M. K., Green, A., Dick, J. P., Gawler, J. & Thompson, E. J. Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease. Neurology 52, 1289-1291 (1999). (Pubitemid 29177941)
112. Campbell, I. L., Eddleston, M., Kemper, P., Oldstone, M. B. & Hobbs, M. V. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68, 2383-2387 (1994). (Pubitemid 24091917)
113. Kordek, R. et al. Heightened expression of tumor necrosis factor-, interleukin-, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl Acad. Sci. USA 93, 9754-9758 (1996). (Pubitemid 26296681)
114. Walsh, D. T., Betmouni, S. & Perry, V. H. Absence of detectable IL-1 production in murine prion disease: a model of chronic neurodegeneration. J. Neuropathol. Exp. Neurol. 60, 173-182 (2001). (Pubitemid 32172420)
115. Baker, C. A., Lu, Z. Y., Zaitsev, I. & Manuelidis, L. Microglial activation varies in different models of Creutzfeldt-Jakob disease. J. Virol. 73, 5089-5097 (1999). (Pubitemid 29246771)
116. Stoeck, K. et al. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch. Neurol. 62, 1591-1594 (2005). (Pubitemid 41434566)
117. Schultz, J. et al. Role of interleukin-1 in prion disease-associated astrocyte activation. Am. J. Pathol. 165, 671-678 (2004). (Pubitemid 38971396)
118. Tamguney, G. et al. Genes contributing to prion pathogenesis. J. Gen. Virol. 89, 1777-1788 (2008).
119. Akhtar, S. et al. Sod1 deficiency reduces incubation time in mouse models of prion disease. PLoS ONE 8, e54454 (2013).
120. Thackray, A. M., McKenzie, A. N., Klein, M. A., Lauder, A. & Bujdoso, R. Accelerated prion disease in the absence of interleukin-10. J. Virol. 78, 13697-13707 (2004). (Pubitemid 39612768)
121. Felton, L. M. et al. MCP-1 and murine prion disease: separation of early behavioural dysfunction from overt clinical disease. Neurobiol. Dis. 20, 283-295 (2005). (Pubitemid 41476256)
122. O'Shea, M. et al. Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse. Genetics 180, 559-566 (2008).
123. LaCasse, R. A., Striebel, J. F., Favara, C., Kercher, L. & Chesebro, B. Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression. J. Neuroimmunol. 196, 16-26 (2008).
124. Riemer, C., Queck, I., Simon, D., Kurth, R. & Baier, M. Identification of upregulated genes in scrapie-infected brain tissue. J. Virol. 74, 10245-10248 (2000).
125. Riemer, C. et al. Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/-mice. J. Virol. 82, 12464-12471 (2008).
126. Baker, C. A., Martin, D. & Manuelidis, L. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J. Virol. 76, 10905-10913 (2002). (Pubitemid 35176207)
127. Fuhrmann, M. et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nature Neurosci. 13, 411-413 (2010).
128. Hughes, P. M., Botham, M. S., Frentzel, S., Mir, A. & Perry, V. H. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37, 314-327 (2002).
129. Xie, W. L. et al. Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K. J. Mol. Neurosci. 51, 919-932 (2013).
130. Kim, J. I. et al. Expression of cytokine genes and increased nuclear factor-B activity in the brains of scrapie-infected mice. Brain Res. Mol. Brain Res. 73, 17-27 (1999).
131. Bourteele, S. et al. Alteration of NF-B activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell. Microbiol. 9, 2202-2217 (2007). (Pubitemid 47250292)
132. Julius, C. et al. Prion propagation in mice lacking central nervous system NF-B signalling. J. Gen. Virol. 89, 1545-1550 (2008).
133. Bremer, J. et al. Repetitive immunization enhances the susceptibility of mice to peripherally administered prions. PLoS ONE 4, e7160 (2009).
134. Michel, B. et al. Genetic depletion of complement receptors CD21/35 prevents terminal prion disease in a mouse model of chronic wasting disease. J. Immunol. 189, 4520-4527 (2012).
135. Sethi, S., Lipford, G., Wagner, H. & Kretzschmar, H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360, 229-230 (2002). (Pubitemid 34804655)
136. Heikenwalder, M. et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nature Med. 10, 187-192 (2004). (Pubitemid 38524890)
137. Gabizon, R., McKinley, M. P., Groth, D. & Prusiner, S. B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl Acad. Sci. USA 85, 6617-6621 (1988).
138. Enari, M., Flechsig, E. & Weissmann, C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl Acad. Sci. USA 98, 9295-9299 (2001). (Pubitemid 32743910)
139. Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743 (2001). (Pubitemid 32771997)
140. Schenk, D. et al. Immunization with amyloid-attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999). (Pubitemid 29327547)
141. Heppner, F. L. et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182 (2001). (Pubitemid 32952973)
142. Souan, L. et al. Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur. J. Immunol. 31, 2338-2346 (2001). (Pubitemid 32785352)
143. Sigurdsson, E. M. et al. Immunization delays the onset of prion disease in mice. Am. J. Pathol. 161, 13-17 (2002). (Pubitemid 34760765)
144. Polymenidou, M. et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl Acad. Sci. USA 101 (Suppl. 2), 14670-14676 (2004). (Pubitemid 39346741)
145. Xanthopoulos, K. et al. Immunization with recombinant prion protein leads to partial protection in a murine model of TSEs through a novel mechanism. PLoS ONE 8, e59143 (2013).
146. Fernandez-Borges, N. et al. DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J. Virol. 80, 9970-9976 (2006). (Pubitemid 44522591)
147. White, A. R. et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80-83 (2003). (Pubitemid 36323299)
148. Sigurdsson, E. M. et al. Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci. Lett. 336, 185-187 (2003). (Pubitemid 36044608)
149. Sadowski, M. J. et al. Anti-PrP Mab 6D11 suppresses PrPSc replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo. Neurobiol. Dis. 34, 267-278 (2009).
150. Petsch, B. et al. Biological effects and use of PrPSc-and PrP-specific antibodies generated by immunization with purified full-length native mouse prions. J. Virol. 85, 4538-4546 (2011).
151. Lefebvre-Roque, M. et al. Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice. Prion 1, 198-206 (2007).
152. Wuertzer, C. A., Sullivan, M. A., Qiu, X. & Federoff, H. J. CNS delivery of vectored prion-specific single-chain antibodies delays disease onset. Mol. Ther. 16, 481-486 (2008). (Pubitemid 351314986)
153. Solforosi, L. et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514-1516 (2004). (Pubitemid 38314420)
154. Sonati, T. et al. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature 501, 102-106 (2013).
155. Mackay, F. & Browning, J. L. Turning off follicular dendritic cells. Nature 395, 26-27 (1998).
156. Meier, P. et al. Soluble dimeric prion protein binds PrPSc in vivo and antagonizes prion disease. Cell 113, 49-60 (2003). (Pubitemid 36411959)
157. Moore, R. C. et al. Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nature Genet. 18, 118-125 (1998). (Pubitemid 28082457)
158. Bueler, H. et al. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19-30 (1994).
159. Sakaguchi, S. et al. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380, 528-531 (1996). (Pubitemid 26110641)
160. Moore, R. C. et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292, 797-817 (1999). (Pubitemid 29465475)
161. Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874 (2003). (Pubitemid 37339628)
162. Prusiner, S. B. et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63, 673-686 (1990). (Pubitemid 120035041)
163. Fischer, M. et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15, 1255-1264 (1996). (Pubitemid 26093461)
164. Scott, M. et al. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59, 847-857 (1989). (Pubitemid 20022375)
165. Telling, G. C. et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90 (1995).
166. Shmerling, D. et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203-214 (1998). (Pubitemid 28180854)
167. Sigurdson, C. J. et al. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc. Natl Acad. Sci. USA 106, 304-309 (2009).
168. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-oligomers. Nature 457, 1128-1132 (2009).
169. Larson, M. et al. The complex PrPC-Fyn couples human oligomeric A with pathological tau changes in Alzheimer's disease. J. Neurosci. 32, 16857-16871 (2012).
170. Gimbel, D. A. et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367-6374 (2010).
171. Um, J. W. et al. Alzheimer amyloid-oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nature Neurosci. 15, 1227-1235 (2012).
172. Balducci, C. et al. Synthetic amyloid-oligomers impair long-term memory independently of cellular prion protein. Proc. Natl Acad. Sci. USA 107, 2295-2300 (2010).
173. Calella, A. M. et al. Prion protein and A-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314 (2010).
174. Kessels, H. W., Nguyen, L. N., Nabavi, S. & Malinow, R. The prion protein as a receptor for amyloid-. Nature 466, E3-E4 (2010).
175. Alzualde, A. et al. Somatic mosaicism in a case of apparently sporadic Creutzfeldt-Jakob disease carrying a de novo D178N mutation in the PRNP gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 1283-1291 (2010).
176. Schwarz, A. et al. Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci. Lett. 350, 187-189 (2003). (Pubitemid 37205197)
177. Goni, F. et al. High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience 153, 679-686 (2008).
178. Bade, S., Baier, M., Boetel, T. & Frey, A. Intranasal immunization of Balb/c mice against prion protein attenuates orally acquired transmissible spongiform encephalopathy. Vaccine 24, 1242-1253 (2006). (Pubitemid 43222031)
179. Pilon, J. et al. Anti-prion activity generated by a novel vaccine formulation. Neurosci. Lett. 429, 161-164 (2007). (Pubitemid 350161127)
180. Ishibashi, D. et al. Immunization with recombinant bovine but not mouse prion protein delays the onset of disease in mice inoculated with a mouse-adapted prion. Vaccine 25, 985-992 (2007). (Pubitemid 44937461)
181. Nitschke, C. et al. Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie. Vet. Microbiol. 123, 367-376 (2007). (Pubitemid 47088864)
182. Sacquin, A., Bergot, A. S., Aucouturier, P. & Bruley-Rosset, M. Contribution of antibody and T cell-specific responses to the progression of 139A-scrapie in C57BL/6 mice immunized with prion protein peptides. J. Immunol. 181, 768-775 (2008).
183. Tayebi, M., Collinge, J. & Hawke, S. Unswitched immunoglobulin M response prolongs mouse survival in prion disease. J. Gen. Virol. 90, 777-782 (2009).
184. Rosset, M. B. et al. Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie. PLoS ONE 4, e4917 (2009).
185. Bachy, V. et al. Mouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie. J. Gen. Virol. 91, 809-820 (2010).
186. Ishibashi, D. et al. Antigenic mimicry-mediated anti-prion effects induced by bacterial enzyme succinylarginine dihydrolase in mice. Vaccine 29, 9321-9328 (2011).
187. Roettger, Y. et al. Immunotherapy in prion disease. Nature Rev. Neurol. 9, 98-105 (2013).